Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN2 | Q96KS0 | 2/20 | 0.49 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.49 |
| ▸ | CTSA | P10619 | 5/20 | 0.47 |
| ▸ | CYP26A1 | O43174 | 5/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.44 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.44 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.43 |
| ▸ | EEF2K | O00418 | 2/20 | 0.41 |
| ▸ | RXRA | P19793 | 1/20 | 0.41 |
| ▸ | RXRB | P28702 | 1/20 | 0.41 |
| ▸ | RXRG | P48443 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15636384 | 0.93 | CTSA (0.53) | EGLN2EGLN1CTSACYP26A1 | |
| SCHEMBL15636578 | 0.92 | EGLN2 (0.52) | EGLN2EGLN1CTSACYP26A1EEF2K | |
| SCHEMBL15637304 | 0.91 | EGLN2 (0.46) | EGLN2EGLN1CTSACYP26A1EEF2K | |
| SCHEMBL15636129 | 0.90 | EGLN2 (0.46) | EGLN2EGLN1CTSACYP26A1 | |
| SCHEMBL15636873 | 0.90 | CTSA (0.47) | EGLN2EGLN1CTSAEEF2K | |
| SCHEMBL15635631 | 0.90 | CTSA (0.54) | EGLN2EGLN1CTSACYP26A1 | |
| SCHEMBL15636227 | 0.90 | CTSA (0.54) | EGLN2EGLN1CTSACYP26A1 | |
| SCHEMBL15635884 | 0.88 | CTSA (0.52) | CTSACYP26A1 | |
| SCHEMBL15636772 | 0.88 | CTSA (0.52) | CTSACYP26A1 | |
| SCHEMBL15636942 | 0.88 | CTSA (0.52) | CTSACYP26A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014053533-A1 | USE OF SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AS PHARMACEUTICALS FOR PREVENTION/TREATMENT OF ATRIAL FIBRILLATION | SANOFI (FR) | 2014-04-10 | — | — | WO | disclosed |